Literature DB >> 19671784

The Euro-lupus project: epidemiology of systemic lupus erythematosus in Europe.

R Cervera1, M A Khamashta, G R V Hughes.   

Abstract

The Euro-lupus project provides updated information on the epidemiologic characteristics of systemic lupus erythematosus (SLE) at the change of the millennium and defines several clinical and immunological prognostic factors. The Euro-lupus cohort is composed of 1000 patients with SLE who have been followed prospectively since 1991. Among other findings, this project has shown that a) the age at onset of the disease, the gender and the autoantibody pattern, among other factors, modify the disease expression and define some specific SLE subsets; b) most of the SLE inflammatory manifestations are less common after long-term evolution of the disease, thus probably reflecting the effect of therapy as well as the progressive remission of the disease in many patients and c) a more prominent role of thrombotic events is becoming evident affecting both morbidity and mortality in SLE.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19671784     DOI: 10.1177/0961203309106831

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  40 in total

Review 1.  Late-onset systemic lupus erythematosus: epidemiology, diagnosis and treatment.

Authors:  Laurent Arnaud; Alexis Mathian; Jacques Boddaert; Zahir Amoura
Journal:  Drugs Aging       Date:  2012-03-01       Impact factor: 3.923

Review 2.  The impact of anti-U1-RNP positivity: systemic lupus erythematosus versus mixed connective tissue disease.

Authors:  Alina Dima; Ciprian Jurcut; Cristian Baicus
Journal:  Rheumatol Int       Date:  2018-05-23       Impact factor: 2.631

Review 3.  [Lupus erythematosus].

Authors:  C Günther; S Beissert
Journal:  Hautarzt       Date:  2015-08       Impact factor: 0.751

4.  Current state and future directions of autologous hematopoietic stem cell transplantation in systemic lupus erythematosus.

Authors:  Gabor G Illei; Ricard Cervera; Richard K Burt; Andrea Doria; Falk Hiepe; David Jayne; Steven Pavletic; Thierry Martin; Alberto Marmont; Riccardo Saccardi; Alexandre E Voskuyl; Dominique Farge
Journal:  Ann Rheum Dis       Date:  2011-08-26       Impact factor: 19.103

5.  A retrospective study of joint infections in patients with systemic lupus erythematosus.

Authors:  Lin Qiao; Dong Xu; Yan Zhao; Xiaofeng Zeng; Fengchun Zhang
Journal:  Clin Rheumatol       Date:  2017-07-08       Impact factor: 2.980

Review 6.  CRDC: a Chinese rheumatology research platform.

Authors:  Mengtao Li; Xinping Tian; Wen Zhang; Xiaomei Leng; Xiaofeng Zeng
Journal:  Clin Rheumatol       Date:  2015-07-11       Impact factor: 2.980

7.  Plasma melatonin levels do not differ in SLE patients.

Authors:  P Wang; H-M Li; Y-F Zou; J-H Tao; H-F Pan
Journal:  Z Rheumatol       Date:  2018-02       Impact factor: 1.372

8.  Burden of systemic lupus erythematosus in Taiwan: a population-based survey.

Authors:  Kuo-Wei Yeh; Chong-Hua Yu; Pei-Chun Chan; Jorng-Tzong Horng; Jing-Long Huang
Journal:  Rheumatol Int       Date:  2013-01-12       Impact factor: 2.631

9.  Clinical and laboratory manifestations of yemeni patients with systemic lupus erythematosus.

Authors:  Hassan A Al-Shamahy; Najla H M Dhaifallah; Yahya M Al-Ezzy
Journal:  Sultan Qaboos Univ Med J       Date:  2014-01-27

10.  Novel estrogen target gene ZAS3 is overexpressed in systemic lupus erythematosus.

Authors:  Nicholas A Young; Alexandra K Friedman; Benjamin Kaffenberger; Murugesan V S Rajaram; Daniel J Birmingham; Brad H Rovin; Lee A Hebert; Larry S Schlesinger; Lai-Chu Wu; Wael N Jarjour
Journal:  Mol Immunol       Date:  2012-11-22       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.